Compare BNTC & RREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | RREV |
|---|---|---|
| Founded | 1995 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.4M | 330.0M |
| IPO Year | 2020 | 2026 |
| Metric | BNTC | RREV |
|---|---|---|
| Price | $7.92 | $9.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $23.75 | N/A |
| AVG Volume (30 Days) | ★ 154.2K | 143.2K |
| Earning Date | 11-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.89 | $9.86 |
| 52 Week High | $14.39 | $9.94 |
| Indicator | BNTC | RREV |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 56.01 |
| Support Level | N/A | $9.89 |
| Resistance Level | $13.87 | $9.94 |
| Average True Range (ATR) | 0.66 | 0.01 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 5.18 | 75.00 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
RRE Ventures Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.